Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BBW
|
Point72 Asset Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,550,000 Reduced 51.95% |
$7,858,500
$5.07 p/Share
|
Mar 13
2019 |
|
OSG
|
Cyrus Capital Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 8,585,152 Added 32.34% |
$16,311,789
$1.9 p/Share
|
Mar 13
2019 |
|
MNTV
|
Tiger Global Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 51,682 Reduced 0.36% |
$803,138
$15.54 p/Share
|
Mar 13
2019 |
|
MNTV
|
Tiger Global Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,618 Reduced 0.17% |
$25,144
$15.54 p/Share
|
Mar 13
2019 |
|
AYX
|
Insight Holdings Group, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 1,250,000 Reduced 78.74% |
-
|
Mar 13
2019 |
|
AYX
|
Insight Holdings Group, LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 1,250,000 Added 44.05% |
-
|
Mar 13
2019 |
|
AYX
|
Insight Holdings Group, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 1,250,000 Reduced 78.74% |
-
|
Mar 13
2019 |
|
AYX
|
Insight Holdings Group, LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 1,250,000 Added 44.05% |
-
|
Mar 13
2019 |
|
AYX
|
Insight Holdings Group, LLC
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect | 31,083 Added 23.88% |
-
|
Mar 13
2019 |
|
CB
|
John J Lupica
Vice Chrm, Chubb Group* |
SELL
Open market or private sale
|
Direct | 17,879 Reduced 8.51% |
$2,412,771
$134.95 p/Share
|
Mar 13
2019 |
|
BRY
|
Benefit Street Partners LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 76,512 Reduced 100.0% |
$886,774
$11.59 p/Share
|
Mar 13
2019 |
|
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 132,738 Reduced 5.54% |
$281,405
$2.12 p/Share
|
Mar 13
2019 |
|
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 348,810 Reduced 100.0% |
$23,122,615
$66.29 p/Share
|
Mar 13
2019 |
|
PLNT
|
Christopher Rondeau |
BUY
Conversion of derivative security
|
Indirect | 348,810 Added 50.0% |
-
|
Mar 13
2019 |
|
FNKO
|
Fundamental Capital Partners, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 203,489 Reduced 47.35% |
$4,159,315
$20.44 p/Share
|
Mar 13
2019 |
|
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 103,035 Reduced 100.0% |
$7,969,757
$77.35 p/Share
|
Mar 13
2019 |
|
SQ
|
Jack Dorsey
Block Head and Chairperson |
BUY
Conversion of derivative security
|
Indirect | 103,035 Added 50.0% |
-
|
Mar 13
2019 |
|
ARE
|
James H Richardson
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 6.25% |
$424,380
$141.46 p/Share
|
Mar 13
2019 |
|
DFRG
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 50,000 Added 1.05% |
$395,000
$7.9 p/Share
|
Mar 13
2019 |
|
DFRG
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 3.61% |
$106,000
$5.3 p/Share
|
Mar 13
2019 |
|
EXC
|
Joseph Nigro
Sr EVP & CFO |
SELL
Open market or private sale
|
Direct | 53,800 Reduced 54.03% |
$2,667,942
$49.59 p/Share
|
Mar 13
2019 |
|
EXC
|
Joseph Nigro
Sr EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,800 Added 3.68% |
$175,142
$46.09 p/Share
|
Mar 13
2019 |
|
WTM
|
Morgan W Davis
Director |
SELL
Open market or private sale
|
Indirect | 631 Reduced 5.94% |
$572,910
$907.94 p/Share
|
Mar 13
2019 |
|
ORI
|
Charles J Kovaleski
Director |
BUY
Open market or private purchase
|
Direct | 200 Added 3.46% |
$4,188
$20.94 p/Share
|
Mar 13
2019 |
|
L
|
Richard Waldo Scott
SVP & Chief Investment Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 17,909 Reduced 43.7% |
$852,110
$47.58 p/Share
|
Mar 13
2019 |
|
L
|
Richard Waldo Scott
SVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 22,500 Added 35.44% |
$852,075
$37.87 p/Share
|
Mar 13
2019 |
|
L
|
Richard Waldo Scott
SVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct | 4,591 Reduced 19.9% |
$219,450
$47.8 p/Share
|
Mar 13
2019 |
|
PNFP
|
Harold R Carpenter
EVP & CFO |
SELL
Open market or private sale
|
Direct | 10,075 Reduced 10.44% |
$581,831
$57.75 p/Share
|
Mar 13
2019 |
|
PNFP
|
Gregory L Burns
Director |
SELL
Open market or private sale
|
Direct | 3,454 Reduced 10.71% |
$200,367
$58.01 p/Share
|
Mar 13
2019 |
|
NEE
|
Manoochehr K Nazar
President, Nuclear Div and CNO |
SELL
Open market or private sale
|
Direct | 36,807 Reduced 24.7% |
$6,988,545
$189.87 p/Share
|
Mar 13
2019 |
|
NEE
|
Manoochehr K Nazar
President, Nuclear Div and CNO |
BUY
Exercise of conversion of derivative security
|
Direct | 19,925 Added 11.79% |
$907,982
$45.57 p/Share
|
Mar 13
2019 |
|
ABT
|
Roger Bird
SENIOR VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 9,188 Reduced 13.32% |
$726,495
$79.07 p/Share
|
Mar 13
2019 |
|
MRK
|
Kenneth C Frazier
Executive Chair |
SELL
Open market or private sale
|
Direct | 18,725 Reduced 2.29% |
$1,535,450
$82.0 p/Share
|
Mar 13
2019 |
|
MRK
|
Kenneth C Frazier
Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct | 18,725 Added 2.24% |
$735,705
$39.29 p/Share
|
Mar 13
2019 |
|
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 100.0% |
$2,697,600
$67.44 p/Share
|
Mar 13
2019 |
|
PLNT
|
Christopher Rondeau |
BUY
Conversion of derivative security
|
Indirect | 40,000 Added 50.0% |
-
|
Mar 13
2019 |
|
FSLR
|
Alexander R. Bradley
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 227 Reduced 2.55% |
$12,272
$54.06 p/Share
|
Mar 13
2019 |
|
ADI
|
James Champy
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 13.98% |
-
|
Mar 13
2019 |
|
ADI
|
Lisa T Su
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 14.22% |
-
|
Mar 13
2019 |
|
ADI
|
Bruce R Evans
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 2.47% |
-
|
Mar 13
2019 |
|
ADI
|
Neil S Novich
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 7.97% |
-
|
Mar 13
2019 |
|
ADI
|
Edward H. Frank
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 18.85% |
-
|
Mar 13
2019 |
|
ADI
|
Mark M Little
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 30.96% |
-
|
Mar 13
2019 |
|
ADI
|
Kenton J Sicchitano
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 8.78% |
-
|
Mar 13
2019 |
|
ADI
|
Ray Stata
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,155 Added 1.38% |
-
|
Mar 13
2019 |
|
ADI
|
Karen Golz
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,504 Added 50.0% |
-
|
Mar 13
2019 |
|
ADI
|
Anantha P. Chandrakasan
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 450 Added 50.0% |
-
|
Mar 13
2019 |
|
TRU
|
David E Wojczynski
Former President, Healthcare |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 20.74% |
$593,460
$65.94 p/Share
|
Mar 13
2019 |
|
TRU
|
David E Wojczynski
Former President, Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct | 9,000 Added 17.18% |
$77,130
$8.57 p/Share
|
Mar 13
2019 |
|
WOW
|
Crestview Partners Iii Gp, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 65,080 Added 0.22% |
$529,100
$8.13 p/Share
|
Mar 13
2019 |